Biostatistics Practice Questions

Q: In the calculation of crude death rate, which point in the year is the population typically considered?

July 1st. ### Explanation **Correct Answer: B. July 1st** In biostatistics and demography, the **Crude Death Rate (CDR)** is defined as the number of deaths per 1,000 population in a given year. The denominator used for this calculation is the **Mid-Year Population**. **Why July 1st?** The population of any region is dynamic, changing daily due to births, deaths, and migration. To represent the average population exposed to the risk of death throughout the entire year, we use the population as it stands on **July 1st** (the exact midpoint of the calendar year). This "Mid-Year Population" acts as an estimate of the average person-years lived by the population during that year. **Analysis of Incorrect Options:** * **A. March 1st:** In India, the National Census (conducted every 10 years) traditionally uses March 1st as the reference date for enumeration. However, for annual vital statistics like CDR, the mid-year estimate is preferred. * **C. April 1st:** This marks the beginning of the financial year in India but holds no specific statistical significance for calculating demographic rates. * **D. August 15th:** While significant as India’s Independence Day, it is not a standard reference point for demographic data. **High-Yield Clinical Pearls for NEET-PG:** * **Mid-Year Population** is the standard denominator for most annual vital rates, including Crude Birth Rate (CBR) and General Fertility Rate (GFR). * **Crude Death Rate** is "crude" because it does not account for the age and sex composition of the population. * **Age-Specific Death Rate** is considered a better indicator of the health status of a specific cohort. * **Standardized Death Rate** is the best tool for comparing mortality between two different populations (e.g., two different states or countries) as it eliminates the bias of age distribution.

Q: Which of the following methods is ideal to ensure similarity between experimental and control groups?

Stratified randomization. **Explanation:** In experimental studies, the goal is to ensure that the study and control groups are as identical as possible, except for the intervention being tested. **1. Why Stratified Randomization is Correct:** While simple randomization ensures that every participant has an equal chance of being assigned to a group, it may fail to balance specific prognostic factors (like age, sex, or disease severity) in smaller samples. **Stratified Randomization** is the ideal method because it first categorizes participants into "strata" based on these important variables and then performs randomization within each stratum. This guarantees that both groups are perfectly balanced for known confounding factors, ensuring maximum similarity. **2. Analysis of Incorrect Options:** * **Randomization (Simple):** This is the "heart" of a clinical trial and eliminates selection bias. However, by chance, it may result in an imbalance of key variables between groups, especially in small studies. * **Matching:** This is primarily used in **Case-Control studies** to eliminate confounding. It is difficult, time-consuming, and can lead to "over-matching." It does not account for unknown confounders, whereas randomization does. * **Cross-over Study:** This is a study design where the same subject serves as their own control (receiving both treatment and placebo at different times). While it ensures perfect similarity, it is a **design type**, not a method used to *create* groups in a standard parallel trial. **High-Yield Pearls for NEET-PG:** * **Randomization** is the best method to control for **unknown confounders**. * **Blinding** is used to eliminate **ascertainment (observer) bias**. * **Stratification** is used to control for **known confounders** at the design stage. * The "Unit of Randomization" in a standard Clinical Trial is the **Individual**, while in a Community Trial, it is the **Group/Community**.

Q: What is an ogive?

Cumulative frequency curve. ### Explanation **Correct Answer: C. Cumulative frequency curve** An **Ogive** (also known as a cumulative frequency polygon) is a graphical representation of the cumulative frequency of a dataset. It is constructed by plotting the cumulative frequencies (either "less than" or "more than" type) against the upper or lower class boundaries. * **Why it is correct:** In biostatistics, while a frequency polygon shows the distribution of data points, the Ogive specifically tracks the **running total**. It is the primary tool used to determine the **Median**, quartiles, and percentiles of a distribution graphically. The point where the "less than" and "more than" ogives intersect corresponds to the Median on the x-axis. **Analysis of Incorrect Options:** * **A. Bar Chart:** Used for **qualitative (categorical)** or discrete data. Bars are separated by spaces. * **B. Histogram:** Used for **continuous quantitative** data. It consists of adjacent rectangles where the area represents the frequency. It is used to find the **Mode** graphically. * **D. Frequency Polygon:** A line graph formed by joining the midpoints of the tops of the bars in a histogram. It represents the frequency distribution of continuous data but does not show cumulative totals. **High-Yield NEET-PG Pearls:** 1. **Median** is determined by the **Ogive**. 2. **Mode** is determined by the **Histogram**. 3. **Mean** cannot be determined graphically; it must be calculated. 4. **Normal Distribution:** In a perfectly symmetrical bell-shaped curve, the Mean, Median, and Mode coincide at the same point. 5. **Scatter Diagram:** Used to show the **correlation** (relationship) between two continuous variables.

Q: All of the following are examples of a nominal scale except?

Body weight. To master Biostatistics for NEET-PG, it is essential to distinguish between the four levels of measurement: **Nominal, Ordinal, Interval, and Ratio.** ### **Why "Body Weight" is the Correct Answer** **Body weight** is a **Ratio Scale** (a type of quantitative/numerical data). Unlike nominal scales, it has a natural order, equal intervals between values, and a **true zero point** (0 kg means the absence of weight). Because it represents a measurable quantity rather than a descriptive category, it is not a nominal scale. ### **Analysis of Other Options** * **A. Race:** This is a **Nominal Scale**. It categorizes individuals into groups (e.g., Caucasian, Asian, African) based on names or labels. There is no inherent mathematical order or ranking between these groups. * **B. Sex:** This is a **Nominal Scale** (specifically a dichotomous/binary scale). Male and female are distinct categories with no quantitative value or rank. * **D. Socio-economic status:** This is typically an **Ordinal Scale** (e.g., Upper, Middle, Lower class). While it is qualitative like a nominal scale, it has a specific **rank or order**. However, in the context of this question, it is still a "categorical" variable and definitely not a "ratio" scale like body weight, making body weight the most distinct outlier. ### **High-Yield Clinical Pearls for NEET-PG** * **NOIR Mnemonic:** **N**ominal (Labels), **O**rdinal (Order/Rank), **I**nterval (No true zero, e.g., Temperature in Celsius), **R**atio (True zero, e.g., BP, Pulse, Height). * **Nominal Data:** The only central tendency measure applicable is the **Mode**. * **Ordinal Data:** Examples include Pain Scales (VAS), Cancer Staging (TNM), and Likert Scales. The **Median** is the preferred measure of central tendency. * **Ratio Data:** This is the "highest" level of measurement and allows for the most complex statistical tests.

Q: All of the following are true about case-control studies except?

Less prone to bias. **Explanation:** The correct answer is **D (Less prone to bias)** because case-control studies are, in fact, **highly prone to bias**, particularly **Recall Bias** and **Selection Bias**. Since these studies are retrospective (looking backward from effect to cause), they rely heavily on the memory of participants or past medical records, which may be incomplete or inaccurate. **Analysis of Options:** * **A. Rapid and inexpensive:** This is true. Unlike cohort studies, case-control studies do not require long-term follow-up. They use existing data or interviews, making them the quickest and cheapest observational study design. * **B. No risk to subjects:** This is true. Because the investigator does not intervene or administer any drug/exposure (it is purely observational) and the outcome has already occurred, there is no physical risk to the participants. * **C. Risk factor can be identified:** This is true. Case-control studies are ideal for generating hypotheses and identifying potential risk factors (associations) for a disease, especially rare diseases. **Clinical Pearls for NEET-PG:** * **Measure of Association:** The Odds Ratio (OR) is the key statistic used in case-control studies. * **Rare Diseases:** Case-control studies are the **study of choice** for rare diseases (e.g., specific cancers). * **Nesting:** A "Nested Case-Control Study" is one conducted within a large cohort study, which helps reduce selection and information bias. * **Direction:** The direction of inquiry is **Backward** (Effect $\rightarrow$ Cause).

Q: The validity of a diagnostic test is based upon all of the following except:

Precision. ### Explanation The core concept of this question lies in distinguishing between **Validity** and **Reliability** in biostatistics. **Why Precision is the Correct Answer:** **Precision** (also known as **Reliability** or Repeatability) refers to the consistency of a test. It is the ability of a test to produce the same results when repeated under the same conditions. While a test can be highly precise (giving the same result every time), it may still be wrong. Therefore, precision is a measure of consistency, not validity. **Why the other options are incorrect (Components of Validity):** **Validity** (also known as **Accuracy**) refers to the ability of a test to measure what it is actually intended to measure—how close the result is to the "true" value (Gold Standard). * **Sensitivity (Option A):** A component of validity; it measures the ability of a test to correctly identify those with the disease (True Positives). * **Specificity (Option B):** A component of validity; it measures the ability of a test to correctly identify those without the disease (True Negatives). * **Accuracy (Option D):** This is the overall validity of the test, calculated as $(TP + TN) / \text{Total}$. --- ### High-Yield Clinical Pearls for NEET-PG: 1. **Validity vs. Reliability Analogy:** Think of a dartboard. * **Valid:** Hitting the bullseye. * **Reliable/Precise:** Hitting the same spot repeatedly (even if it's not the bullseye). 2. **Sensitivity** is used for **Screening** (to rule out disease - SNOUT). 3. **Specificity** is used for **Confirmation** (to rule in disease - SPIN). 4. **Predictive Values** (PPV/NPV) are not inherent properties of a test; they depend heavily on the **prevalence** of the disease in the population, whereas Sensitivity and Specificity remain constant.

Q: The probability of developing Acute Myocardial Infarction (AMI) in a lifetime is 0.75. What are the odds of developing AMI in a lifetime?

3:1. **Explanation:** In biostatistics, it is crucial to distinguish between **Probability** and **Odds**. * **Probability (P):** The likelihood of an event occurring out of the total number of possibilities. It is expressed as: $P = \frac{\text{Events}}{\text{Total Outcomes}}$. * **Odds:** The ratio of the probability of an event occurring to the probability of it *not* occurring. It is expressed as: $\text{Odds} = \frac{P}{1 - P}$. **Calculation for this question:** 1. Given Probability ($P$) = 0.75 (or 3/4). 2. Probability of the event NOT occurring ($1 - P$) = $1 - 0.75 = 0.25$ (or 1/4). 3. $\text{Odds} = \frac{0.75}{0.25} = \frac{3}{1}$ or **3:1**. **Analysis of Options:** * **Option A (3:1):** Correct. For every 4 people, 3 will develop AMI and 1 will not. * **Option B (3:4):** Incorrect. This represents the probability (0.75) expressed as a ratio, not the odds. * **Option C (4:3):** Incorrect. This is the reciprocal of the probability, sometimes used to calculate "Number Needed to Treat" (NNT) in different contexts, but mathematically irrelevant here. * **Option D (1:3):** Incorrect. These are the "odds against" the event, or the odds of *not* developing AMI. **High-Yield Clinical Pearls for NEET-PG:** * **Range:** Probability always ranges between **0 and 1**, whereas Odds can range from **0 to infinity**. * **Case-Control Studies:** The **Odds Ratio (OR)** is the standard measure of association because these studies do not allow for the calculation of incidence or Relative Risk (RR). * **Rare Disease Assumption:** If a disease is rare (prevalence <10%), the Odds Ratio becomes a good approximation of the Relative Risk.

Q: A study on a group of patients showed the coefficient of variance for BP and serum creatinine to be 20% and 15% respectively. What can be inferred?

The variation in BP is more than in serum creatinine.. ### Explanation **1. Why the Correct Answer is Right:** The **Coefficient of Variation (CV)** is a measure of **relative variation**. It is calculated as: $$CV = \frac{\text{Standard Deviation (SD)}}{\text{Mean}} \times 100$$ Unlike Standard Deviation, which measures absolute dispersion in the same units as the data, CV is a dimensionless percentage. It allows for the comparison of variability between two different datasets with different units (e.g., mmHg for BP vs. mg/dL for Creatinine). A **higher CV indicates greater relative dispersion** or less consistency. Since the CV for BP (20%) is higher than for serum creatinine (15%), the variation in BP is relatively greater. **2. Why the Incorrect Options are Wrong:** * **Option B:** This is mathematically incorrect because 15% (Creatinine) is less than 20% (BP). * **Options C & D:** These are incorrect because CV depends on both the SD **and** the Mean. We cannot determine the absolute Standard Deviation without knowing the mean values of the two groups. For example, a high SD with an even higher Mean could result in a low CV. Therefore, CV only tells us about *relative* variation, not *absolute* SD. **3. High-Yield Clinical Pearls for NEET-PG:** * **Unitless Measure:** CV is the best measure to compare the precision of two different laboratory instruments or datasets with different units. * **Precision vs. Accuracy:** In lab medicine, a lower CV indicates higher **precision** (reproducibility). * **Standard Deviation (SD):** Measures the dispersion of data around the mean in a distribution. 1 SD covers 68.2% of values, 2 SD covers 95.4%, and 3 SD covers 99.7% in a Normal Distribution. * **Standard Error (SE):** Measures the dispersion of "sample means" around the "population mean." It is used to calculate Confidence Intervals.

Q: More false positive cases in a community signify that the disease has:

Low prevalence. This question tests the relationship between **Prevalence** and the **Positive Predictive Value (PPV)** of a screening test. ### Why "Low Prevalence" is Correct The number of false positives is inversely related to the prevalence of a disease in a population. * **Positive Predictive Value (PPV)** is the probability that a person who tests positive actually has the disease. * When a disease is rare (**Low Prevalence**), the vast majority of the population is healthy (True Negatives). Even a highly specific test will produce some false positives. Because the actual number of diseased individuals is so small, these "false positives" from the healthy group will outnumber the "true positives" from the diseased group. * Therefore, in a low-prevalence setting, a positive test result is more likely to be a **False Positive** than a True Positive. ### Why Other Options are Incorrect * **A. High Prevalence:** In a high-prevalence population, the number of True Positives increases significantly, which increases the PPV and decreases the proportion of false positives among those who test positive. * **B. High Sensitivity:** Sensitivity relates to the test's ability to identify true cases. High sensitivity reduces **False Negatives**, not false positives. * **D. Low Sensitivity:** Low sensitivity means the test misses many actual cases, leading to more **False Negatives**. ### NEET-PG High-Yield Pearls 1. **Prevalence vs. Predictive Value:** * Prevalence $\uparrow$ = PPV $\uparrow$ (and False Positives $\downarrow$) * Prevalence $\downarrow$ = NPV $\uparrow$ (and False Negatives $\downarrow$) 2. **Screening Strategy:** To minimize false positives in a community, we use a test with **High Specificity**. 3. **Bayes' Theorem:** This is the mathematical principle underlying why predictive values change with prevalence, while Sensitivity and Specificity remain constant properties of the test itself.

Question 1

In the calculation of crude death rate, which point in the year is the population typically considered?

Accepted Answer

July 1st

Answer

March 1st

Answer

April 1st

Answer

August 15th

Question 2

Which of the following methods is ideal to ensure similarity between experimental and control groups?

Accepted Answer

Stratified randomization

Answer

Randomization

Answer

Matching

Answer

Cross-over study

Question 3

What is an ogive?

Accepted Answer

Cumulative frequency curve

Answer

Bar chart

Answer

Histogram

Answer

Frequency polygon

Question 4

All of the following are examples of a nominal scale except?

Accepted Answer

Body weight

Answer

Race

Answer

Sex

Answer

Socio-economic status

Question 5

What type of epidemiological study best establishes the temporal association of a disease?

Accepted Answer

Cohort study

Answer

Case-Control study

Answer

Cross-sectional study

Answer

Descriptive study

Question 6

All of the following are true about case-control studies except?

Accepted Answer

Less prone to bias

Answer

Rapid and inexpensive

Answer

No risk to subjects

Answer

Risk factor can be identified

Question 7

The validity of a diagnostic test is based upon all of the following except:

Accepted Answer

Precision

Answer

Sensitivity

Answer

Specificity

Answer

Accuracy

Question 8

The probability of developing Acute Myocardial Infarction (AMI) in a lifetime is 0.75. What are the odds of developing AMI in a lifetime?

Accepted Answer

3:1

Answer

3:4

Answer

4:3

Answer

1:3

Question 9

A study on a group of patients showed the coefficient of variance for BP and serum creatinine to be 20% and 15% respectively. What can be inferred?

Accepted Answer

The variation in BP is more than in serum creatinine.

Answer

The variation in serum creatinine is more than in BP.

Answer

The standard deviation of BP is more than of creatinine.

Answer

The standard deviation of creatinine is more than of BP.

Question 10

More false positive cases in a community signify that the disease has:

Accepted Answer

Low prevalence

Answer

High prevalence

Answer

High sensitivity

Answer

Low sensitivity

Biostatistics — MCQs

Biostatistics — MCQs

On this page

Practice by Chapter

Want unlimited practice?